Keke Nie | Oncology | Best Researcher Award

Published on by China Scientist

Prof. Dr. Keke Nie | Oncology | Best Researcher Award 

Dr. Keke Nie is a dedicated medical oncologist specializing in thoracic radio-oncology. She currently serves as the Director of Oncology at Qingdao Central Hospital, University of Health and Rehabilitation Sciences. With extensive clinical experience in lung and gastrointestinal cancers, she has led numerous research initiatives focused on improving cancer treatment outcomes. Dr. Nie holds an MD from Weifang Medical University and an MS from Qingdao University Medical School. Her expertise spans clinical trial design, surgical procedures, and medical research, making her a key figure in advancing oncology care in China.

Prof. Dr. Keke Nie | Qingdao Central Hospital | China

Profile

SCOPUS

ORCID

Education

  • Dr. Keke Nie pursued her foundational medical training at Weifang Medical University in China, where she earned her medical degree. She continued her academic journey at Qingdao University Medical School, where she completed a master’s program in clinical medicine. Her formal education laid a strong foundation for her clinical practice and research in the fields of thoracic radio-oncology and medical oncology.

Experience

  • Dr. Nie currently serves as the Director of Oncology at Qingdao Central Hospital, affiliated with the University of Health and Rehabilitation Sciences. In this leadership role, she is actively involved in designing and implementing clinical research studies, particularly in lung cancer and gastrointestinal cancer. Prior to this, she worked for over a decade at Qingdao Cancer Hospital and Institute as an attending physician. There, she was responsible for patient care and clinical investigation, with a focus on lung, colon, breast, and ovarian cancers, especially in the post-surgical context. Her career reflects a continuous dedication to cancer treatment and patient-centered care.

Awards and Recognition

  • Dr. Nie’s appointment as Director of Oncology and her long-standing contributions to leading institutions in Qingdao reflect recognition of her clinical excellence and research capability. Her leadership in designing clinical studies indicates the trust placed in her expertise by the medical and scientific community.

Skills and Expertise

  • Dr. Nie is proficient in various software tools essential for medical research and documentation, including Microsoft Office, Sigmaplot, and Photoshop. She has practical knowledge of clinical trial protocols, including the preparation of new drug studies and the development of novel treatment techniques. In addition, she possesses hands-on surgical experience, particularly in general surgery, which supports her work in oncology care.

Research Focus 

  • Dr. Nie’s primary research interests lie in thoracic radio-oncology and medical oncology. She is especially focused on developing clinical research protocols and conducting studies that enhance treatment outcomes for lung and gastrointestinal cancers. Her experience bridges both clinical practice and laboratory-based research, providing her with a comprehensive understanding of cancer therapeutics.

Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, M Shen
Journal: Autophagy

Protective mechanism of FSH against oxidative damage in mouse ovarian granulosa cells by repressing autophagy
Authors: M Shen, Y Jiang, Z Guan, Y Cao, L Li, H Liu, S Sun
Journal: Autophagy

Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress
Authors: M Shen, F Lin, J Zhang, Y Tang, WK Chen, H Liu
Journal: Journal of Biological Chemistry

miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine Ovary
Authors: F Lin, R Li, ZX Pan, B Zhou, DB Yu, XG Wang, XS Ma, J Han, M Shen
Journal: PLoS One

Melatonin protects mouse granulosa cells against oxidative damage by inhibiting FOXO1-mediated autophagy: Implication of an antioxidation-independent mechanism
Authors: M Shen, Y Cao, Y Jiang, Y Wei, H Liu
Journal: Redox Biology

Conclusion

  • Dr. Keke Nie is a self-motivated and diligent medical professional with extensive experience in thoracic radio-oncology and medical oncology. Her clinical insight, combined with a strong foundation in research and technical skills, makes her a valuable contributor to cancer treatment advancements. With a career marked by commitment to patient care and scientific rigor, she continues to play a pivotal role in shaping clinical oncology research and practice in China.

Ben Wang | Oncology | Best Researcher Award

Published on by China Scientist

Prof . Ben Wang | Oncology | Best Researcher Award

Recognition and Awards:
  •  Dr. Wang has received numerous awards throughout his career, including recognition from the National Science Foundation and various engineering societies. These accolades highlight his consistent contributions to advancing material science.
 Prof. Ben Wang , Zhejiang University , China

Profile

Scopus

OrcID

Google Scholar

🎓Early Academic Pursuits

  • Dr. Wang Ben was born in June 1983 in Qufu, China. His academic journey began with a Bachelor of Science in Chemical Engineering at Qufu Normal University in 2004. He then pursued his Master’s in Biology at Zhejiang University, focusing on the secondary metabolism of endophytic fungi from antitumor plants. His academic excellence earned him a Ph.D. in Chemistry & Biomedical Engineering from Zhejiang University in collaboration with Harvard University in 2011, under the guidance of Prof. Ruikang Tang and Prof. Ali Khademhosseini. His doctoral research focused on cellular shellization and surface engineering for single-cell modification and protection.

💼Professional Endeavors

  • Dr. Wang Ben’s career has been defined by his contributions to cancer metabolism and biomedical engineering. After completing his postdoctoral work at Zhejiang University in 2013, he served as an Associate Professor and Qiushi Young Scholar until 2022, when he was promoted to Professor. His work as Dean Assistant at the Institute of Translational Medicine and Deputy Director of the Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism showcases his leadership and contributions to the academic community. He also serves as a PI at the Cancer Institute of The Second Affiliated Hospital of Zhejiang University.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

  • Dr. Wang’s research primarily revolves around cancer metabolism, cellular engineering, and biomedical innovations. His innovative research in translational medicine seeks to bridge laboratory research with practical clinical applications. Key areas of his research include:
    • Surface engineering for single-cell modification
    • Metabolism-related cancer research
    • Advancements in transvascular implantation devices

    Dr. Wang has also played a critical role as a panel judge for the National Natural Science Foundation of China and has been actively involved in several international research collaborations, contributing to a wide range of scientific publications.

🌍Impact and Influence

  • Dr. Wang’s impact extends beyond research, with significant contributions to education and mentorship. He has undertaken extensive teaching responsibilities, from undergraduate biology courses to graduate thesis guidance, impacting hundreds of students. His mentorship has produced many successful Ph.D. and master’s candidates who have gone on to establish themselves in academia and industry.As a journal reviewer for numerous prestigious scientific publications, including ACS Nano, Advanced Materials, and Biomaterials, Dr. Wang has helped shape the discourse in chemistry, biology, and biomedical engineering fields. His expertise is highly sought after by journals such as Chemical Science and Journal of Controlled Release.

🏅ACADEMIC CITES 

  • Dr. Wang Ben’s research is widely recognized within the academic community, reflected in his growing number of citations. His Google Scholar profile shows a robust citation record, underscoring the influence of his research in both cancer metabolism and biomedical engineering fields.

 📚LEGACY AND FUTURE CONTRIBUTIONS

  • Dr. Wang’s legacy in the field of cancer metabolism and transvascular implantation devices continues to grow. His future work promises to contribute further to cancer treatment, aiming to integrate innovative biomedical solutions into mainstream healthcare. His leadership roles and international collaborations highlight his dedication to driving forward impactful translational medical research.

📰PUBLICATIONS

  • Acid-base transformative HADLA micelles alleviate colitis by restoring adaptive immunity and gut microbiome
    • Authors: Cheng, W.; Zhou, X.; Jin, C.; Ji, F.; Wang, B.
    • Journal: Journal of Controlled Release, 2023, Volume 364, Pages 283–296.
  • Targeted glycan degradation potentiates cellular immunotherapy for solid tumors
    • Authors: Wu, J.; Wang, X.; Huang, Y.; Zhang, J.; Wang, B.
    • Journal: Proceedings of the National Academy of Sciences of the United States of America, 2023, Volume 120(38), Article e2300366120.
  •  A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch
    • Authors: Sun, Y.; He, Q.; Li, J.; Luo, H.; Luo, Y.
    • Journal: Cell Death and Disease, 2023, Volume 14(7), Article 463.
  •  Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD
    • Authors: Zhang, Y.; Wu, J.; An, Q.; Wang, B.; Lin, W.
    • Journal: Nano Research, 2023, Volume 16(7), Pages 9701–9714.
  • Chemoimmunological Cascade Cancer Therapy Using Fluorine Assembly Nanomedicine
    • Authors: Zhang, Q.; Wu, P.; Wu, J.; Wang, S.; Wang, B.
    • Journal: ACS Nano, 2023, Volume 17(8), Pages 7498–7510.